Application 200744

Type
ANDA
Sponsor
FOUGERA PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TACROLIMUSTACROLIMUSOINTMENT;TOPICAL0.03%NoNo
002TACROLIMUSTACROLIMUSOINTMENT;TOPICAL0.1%NoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0093-3428TacrolimustacrolimusTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-3429TacrolimustacrolimusTeva Pharmaceuticals USA, Inc.ANDACurrent
0168-0416TacrolimustacrolimusE. Fougera & Co. a division of Fougera Pharmaceuticals Inc.ANDACurrent
0168-0416TacrolimustacrolimusE. Fougera & Co. a division of Fougera Pharmaceuticals Inc.ANDACurrent
0168-0416TacrolimustacrolimusE. Fougera & Co. a division of Fougera Pharmaceuticals Inc.ANDACurrent
0168-0417TacrolimustacrolimusE. Fougera & Co. a division of Fougera Pharmaceuticals Inc.ANDACurrent
0168-0417TacrolimustacrolimusE. Fougera & Co. a division of Fougera Pharmaceuticals Inc.ANDACurrent
0168-0417TacrolimustacrolimusE. Fougera & Co. a division of Fougera Pharmaceuticals Inc.ANDACurrent
68308-703TacrolimustacrolimusMayne Pharma Inc.ANDACurrent
68308-703TacrolimustacrolimusMayne Pharma Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
58716ORIG2019-05-15
9849ORIG2014-09-10